Drug profile · INN
inotersen
TEGSEDI
inotersen (TEGSEDI) is a transthyretin antisense inhibitor.
EMA: approved Nervous system (N07) N07
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — inotersen
- Class
- Nervous system (N07)
- Route
- —
- Patents
- 0
- Programs
- 2
- Data quality
- 0.83
Quick answer
inotersen (TEGSEDI) is a transthyretin antisense inhibitor.
Key facts
INN inotersen
Brand TEGSEDI
Mechanism Transthyretin ANTISENSE inhibitor
Therapeutic class Nervous system (N07)
ATC code N07
Mechanism of action
Transthyretin ANTISENSE inhibitor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is inotersen?
inotersen (TEGSEDI) is a transthyretin antisense inhibitor.
What is the brand name for inotersen?
TEGSEDI is a marketed brand name for inotersen. Check FDA Drugs@FDA for the current US label holder and prescribing information.